Authors' reply

Gut

Volumn 58, Issue 8, 2009, Pages 1169-1170

  Endo, H ^a   Fujisawa, T ^a   Takahashi, H ^a   Inamori, M ^a   Nakajima, A ^a,b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; LEPTIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE;

CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; COLON CARCINOGENESIS; COLORECTAL CANCER; GLUCOSE HOMEOSTASIS; LETTER; LIPID DIET; NONHUMAN; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 67650221330     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001;131:3109S-20S.
2. Fenton JI, Birmingham JM, Hursting SD, et al. Adiponectin blocks multiple signaling cascades associated with leptin-induced cell proliferation in Apc Min/+ colon epithelial cells. Int J Cancer 2008;122:2437-45.
3. Hardwick JC, Van Den Brink GR, Offerhaus GJ, et al. Leptin is a growth factor for colonic epithelial cells. Gastroenterology 2001;121:79-90.
4. Sugiyama M, Takahashi H, Hosono K, et al. Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol 2009;34:339-44.